| |
| |
|
| Insider
Information: |
Momtazee James C |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
183,342 |
|
|
Indirect Shares
|
9,293,278 |
|
|
| Direct
Value |
$5,237,850 |
|
|
|
Indirect Value
|
$47,823,174 |
|
|
| Total
Shares |
9,476,620 |
|
|
| Total
Value |
$53,061,024 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -20.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Accuride Corp |
ACW |
Director |
|
0 |
2005-10-12 |
7,850,213 |
Premium* |
|
|
Alliance Healthcare Services |
AIQ |
Director |
2007-05-07 |
0 |
2007-03-16 |
1,443,065 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2013-08-13 |
17,315 |
2012-01-11 |
0 |
Premium* |
|
|
Entellus Medical Inc |
ENTL |
Director |
2018-02-28 |
0 |
2017-07-14 |
0 |
Premium* |
|
|
Pra Health Sciences, Inc. |
PRAH |
Director |
2021-07-01 |
0 |
2019-08-13 |
0 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2021-12-29 |
88,491 |
2020-02-12 |
0 |
Premium* |
|
|
Roivant Sciences Ltd. |
ROIV |
|
2024-04-24 |
77,536 |
2022-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2024-04-24 |
4 |
D |
$10.90 |
$3,194 |
D/D |
(293) |
77,536 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2024-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,490 |
77,829 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2024-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,570 |
76,339 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-10-17 |
4 |
AS |
$10.30 |
$7,076 |
D/D |
(687) |
74,769 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-09-18 |
4 |
AS |
$11.17 |
$75,420 |
D/D |
(6,752) |
73,862 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
17,825 |
80,614 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,664 |
62,789 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,351 |
61,125 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,447 |
59,774 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2022-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,404 |
57,327 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2022-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,594 |
75,456 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
|
• • – |
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
53,923 |
0 |
- |
|
| ROIV |
Roivant Sciences Ltd. |
Director |
– • – |
2022-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,923 |
3,923 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2021-12-29 |
4 |
B |
$14.50 |
$1,160,000 |
D/D |
80,000 |
88,491 |
2.39 |
% |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2021-07-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,521) |
0 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
330 |
3,521 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,748 |
3,191 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2020-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,491 |
8,491 |
0 |
- |
|
| PRAH |
Pra Health Sciences, Inc. |
Director |
– • – |
2019-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,443 |
1,443 |
0 |
- |
|
| ENTL |
Entellus Medical Inc |
Director |
– • – |
2018-02-28 |
4 |
D |
$24.00 |
$90,000 |
D/D |
(3,750) |
0 |
0 |
- |
|
| ENTL |
Entellus Medical Inc |
Director |
– • – |
2017-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
3,750 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2013-08-13 |
4 |
S |
$81.86 |
$87,590 |
D/D |
(1,070) |
17,315 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2013-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
18,385 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
16,135 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
16,135 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
